Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » Medicine » Immune Disorders » Autoimmune Disorders: Symptoms, Diagnosis and Treatment Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Special Operations Forces: Elements, Trends in Force Structure and Funding
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266
Tell A Friend
Tell someone you know about this product.
Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266 $100.00
Authors:  (E.W. Brenu, L. Tajouri, D.R. Staines, S. Marshall-Gradisnik, Faculty of Health Science and Medicine, Population Health and Neuroimmunology Unit, Bond University, Robina, Queensland, Australia, and others)
Immunomodulation and immunosuppression are important strategies for monitoring autoimmune disorders. As imbalances in immune function affect other physiological processes, immunomodulators may have an important role in restoring and maintaining regular neuroimmue activities. In recent years these agents have demonstrated important benefits in controlling the mechanisms associated with deteriorating central nervous system pathologies such as Multiple Sclerosis (MS), where central and peripheral nervous system immune regulation is impaired. MS is characterized by severe compromises to neuroimmune processes involving changes in immune cell function, soluble proteins and modulation of inflammatory processes. The introduction of therapeutic agents in the form of immunomodulators; interferon, phosphodiesterase inhibitors and Glatiramer acetate have proven to be useful to some extent in reducing the severity of MS. Herein the implications and effects of these molecules on the immune system in MS are reviewed. Additionally, the available evidence on the mode of action of neuropeptides in MS, their effectiveness on clinical measures, and current knowledge are also reviewed. 

Available Options:
Special Focus Titles
01.Adrenal Glands: From Pathophysiology to Clinical Evidence
02.Misperceptions of Intimate Partner Violence in the 21st Century: Two Decades of Lies
03.Mental and Holistic Health: Some International Perspectives
04.Psychiatry Board Review
05.Youth Suicide Prevention: Everybody’s Business
06.Crisis Management: A Leadership Perspective
07.A Difficult World: Examining the Roots of Capitalism
08.From Medicinal Chemistry to Food Science: A Transfer of In Silico Methods Applications
09.Bioactive Compounds in Wine: Recent Advances and Perspectives
10.A Primer for Swimming Coaches. Volume 2: Biomechanical Foundations
11.Microbiological Food Hygiene
12.Forest Plantation Development and Management in Ghana

Nova Science Publishers
© Copyright 2004 - 2015

Immunomodulators as Therapeutic Strategies for Managing Multiple Sclerosis pp. 249-266